Evidence brief · Supplement

Echinacea for Cold incidence/duration

Evidence grade C — Near-null overall

Overall grade
Grade C
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade C — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Cold incidence/durationEvidence grade C

    Near-null overall

    Smalllow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Cold incidence/duration (grade C).

The evidence in words

The verdict

For cold incidence/duration, Echinacea earns evidence grade C (small effect, low consistency) — the evidence is limited or mixed. Near-null overall

How it might work

Immune-modulating alkamides and polysaccharides; effects vary enormously by species, plant part, and preparation.

How to use it

Standardized extracts at first sign of a cold; benefits, if any, are small.

Safety & cautions

Generally safe; allergy possible (ragweed family); caution in autoimmune disease theoretically.

Bottom line

Mostly disappointing on pooled data, with a slim chance of a small effect from specific preparations. Low-risk, low-yield.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Standard
Standardized extract at onset.

Goes with

  • EchinaceaRead the full Echinacea monographEvidence grade C

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.